Healthcare Example

Navigating multicancer early detection

Challenge

The healthcare community is wrestling with how to evaluate novel multicancer detection (MCED) technologies, which offer the possibility of earlier cancer detection and treatment as well as potential harms from false-positive results.

Response and Impact

Tapestry engaged diverse stakeholders to understand challenges facing MCED adoption and identify approaches for overcoming those challenges. This work laid the foundation for a new independent organization—the MCED Consortium—to address these issues on a long-term basis. Tapestry and collaborators co-designed a Consortium Blueprint that outlined the mission, scope, objectives, governance structure, operating model, and multiyear work plans and deliverables for the new organization. The Consortium launched as an independent entity in 2021.

Setting standards for diagnostic AI

Challenge

Healthcare systems and vendors are rapidly developing and deploying diagnostic AI technologies, but the lack of defined standards raises questions about the value and quality of such technologies.

Response and Impact

The Gordon and Betty Moore Foundation (GBMF) partnered with Tapestry to engage payers, clinicians, and others and produce a landscape analysis on quality advancement in diagnostic AI.

Additionally, stakeholders provided candid feedback on pilot projects being considered for funding. GBMF subsequently established a national coordinating center at UC San Francisco to guide implementation of these pilots.

Advancing shared value in inflammatory bowel disease (IBD)

Challenge

IBD, an umbrella term for two autoimmune diseases—ulcerative colitis and Crohn’s disease—is a medical condition with high variability in cost and outcomes. Some believe that new payment and incentive models that enable proactive, multidisciplinary care and use of advanced drug therapies to manage disease progression would be beneficial. However, structuring new incentives across clinicians, payers, and others is challenging in small sub-specialty disease areas.

Response and Impact

Tapestry, together with payers, clinicians, and others coauthored a payer-provider framework published in Clinical Gastroenterology and Hepatology to establish a shared vision for value-based care (VBC) in IBD as a foundational guidepost for the community. The framework continues to be cited by diverse IBD leaders. Tapestry and the effort’s participants then initiated a deep-dive assessment on enabling timely access to treatment by evolving prior authorization processes, which many identified as a key issue for the subspecialty.